These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
136 related articles for article (PubMed ID: 32874980)
1. Dydrogesterone treatment for menstrual-cycle regularization in abnormal uterine bleeding - ovulation dysfunction patients. Wang L; Guan HY; Xia HX; Chen XY; Zhang W World J Clin Cases; 2020 Aug; 8(15):3259-3266. PubMed ID: 32874980 [TBL] [Abstract][Full Text] [Related]
2. Dydrogesterone treatment for menstrual-cycle regularization in routine clinical practice: a multicenter observational study. Podzolkova N; Tatarchuk T; Doshchanova A; Eshimbetova G; Pexman-Fieth C Gynecol Endocrinol; 2016; 32(3):246-9. PubMed ID: 26613278 [TBL] [Abstract][Full Text] [Related]
3. Effectiveness and safety of dydrogesterone in regularization of menstrual cycle: a post-marketing study. Trivedi N; Chauhan N; Vaidya V Gynecol Endocrinol; 2016 Aug; 32(8):667-671. PubMed ID: 26950060 [TBL] [Abstract][Full Text] [Related]
4. [Acupuncture artificial menstrual cycle method for abnormal uterine bleeding-ovulatory dysfunction (spleen deficiency syndrome)]. Zhang L; Li J; Pan S; Zhang X; Li Y; Hu S; Chen W Zhongguo Zhen Jiu; 2019 May; 39(5):489-94. PubMed ID: 31099219 [TBL] [Abstract][Full Text] [Related]
5. Medroxyprogesterone Acetate for Abnormal Uterine Bleeding Due to Ovulatory Dysfunction: The Effect of 2 Different-Duration Regimens. Bender RA Med Sci Monit; 2022 Jun; 28():e936727. PubMed ID: 35746846 [TBL] [Abstract][Full Text] [Related]
6. Endometrial histology and bleeding patterns in post-menopausal women taking sequential, combined estradiol and dydrogesterone. Ferenczy A; Gelfand MM Maturitas; 1997 Apr; 26(3):219-26. PubMed ID: 9147354 [TBL] [Abstract][Full Text] [Related]
7. Endometrial Ablation in Women With Abnormal Uterine Bleeding Related to Ovulatory Dysfunction: A Cohort Study. Hokenstad AN; El-Nashar SA; Khan Z; Hopkins MR; Famuyide AO J Minim Invasive Gynecol; 2015; 22(7):1225-30. PubMed ID: 26149205 [TBL] [Abstract][Full Text] [Related]
8. The efficacy and safety of dydrogesterone for treatment of dysmenorrhea: An open-label multicenter clinical study. Taniguchi F; Ota I; Iba Y; Toda T; Tagashira Y; Ohata Y; Kurioka H; Endo Y; Sunada H; Noma H; Azuma Y; Harada T J Obstet Gynaecol Res; 2019 Jan; 45(1):168-175. PubMed ID: 30246276 [TBL] [Abstract][Full Text] [Related]
9. Differences in menstrual bleeding characteristics, functional status, and attitudes toward menstruation in three groups of women. Geller SE; Harlow SD; Bernstein SJ J Womens Health Gend Based Med; 1999 May; 8(4):533-40. PubMed ID: 10839708 [TBL] [Abstract][Full Text] [Related]
10. [The efficacy of dydrogesterone in the treatment of menstrual cycle disorders in girls]. Sipowicz I; Chomczyk I Ginekol Pol; 1998 Oct; 69(10):767-70. PubMed ID: 9884472 [TBL] [Abstract][Full Text] [Related]
11. Uterine polypectomy in the management of abnormal uterine bleeding: A systematic review. Nathani F; Clark TJ J Minim Invasive Gynecol; 2006; 13(4):260-8. PubMed ID: 16825064 [TBL] [Abstract][Full Text] [Related]
12. Development and validation of a predictive model of abnormal uterine bleeding associated with ovulatory dysfunction: a case-control study. Zhang Y; Luo Z; Jia Y; Zhao Y; Huang Y; Ruan F; Ying Q; Ma L; Luo J; Zhou J BMC Womens Health; 2023 Oct; 23(1):536. PubMed ID: 37828525 [TBL] [Abstract][Full Text] [Related]
13. Bleeding patterns and endometrial histology during administration of low-dose estradiol sequentially combined with dydrogesterone. van de Weijer PH; Scholten PC; van der Mooren MJ; Barentsen R; Kenemans P Climacteric; 1999 Jun; 2(2):101-9. PubMed ID: 11910662 [TBL] [Abstract][Full Text] [Related]
14. National survey of abnormal uterine bleeding according to the FIGO classification in Japan. Kitahara Y; Hiraike O; Ishikawa H; Kugu K; Takai Y; Yoshino O; Ono M; Maekawa R; Ota I; Iwase A J Obstet Gynaecol Res; 2023 Jan; 49(1):321-330. PubMed ID: 36258286 [TBL] [Abstract][Full Text] [Related]
16. Cyclical dydrogesterone in secondary amenorrhea: results of a double-blind, placebo-controlled, randomized study. Panay N; Pritsch M; Alt J Gynecol Endocrinol; 2007 Nov; 23(11):611-8. PubMed ID: 17891596 [TBL] [Abstract][Full Text] [Related]
17. A prospective, open-label, single-arm study to evaluate the efficacy of dydrogesterone in the treatment of endometrial polyps. Chen Q; Zhang D; Wang S; Lang JH; Chao XP; Fan QB Gynecol Endocrinol; 2021 Feb; 37(2):152-156. PubMed ID: 33274680 [TBL] [Abstract][Full Text] [Related]
18. A dose-ranging study of the use of cyclical dydrogesterone with continuous 17 beta oestradiol. Burch DJ; Spowart KJ; Jesinger DK; Randall S; Smith SK Br J Obstet Gynaecol; 1995 Mar; 102(3):243-8. PubMed ID: 7794851 [TBL] [Abstract][Full Text] [Related]
19. New application of dydrogesterone as a part of a progestin-primed ovarian stimulation protocol for IVF: a randomized controlled trial including 516 first IVF/ICSI cycles. Yu S; Long H; Chang HY; Liu Y; Gao H; Zhu J; Quan X; Lyu Q; Kuang Y; Ai A Hum Reprod; 2018 Feb; 33(2):229-237. PubMed ID: 29300975 [TBL] [Abstract][Full Text] [Related]
20. Effective post-laparoscopic treatment of endometriosis with dydrogesterone. Trivedi P; Selvaraj K; Mahapatra PD; Srivastava S; Malik S Gynecol Endocrinol; 2007 Oct; 23 Suppl 1():73-6. PubMed ID: 17943543 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]